Europe Drug Delivery Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028

Analysis- by Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)

No. of Pages: 247
Report Code: BMIRE00028754
Category: Life Sciences
Europe Drug Delivery Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Drug Delivery Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Drug Delivery Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Drug Delivery Market Regional Analysis

6.2 Europe Drug Delivery Market Revenue 2021-2028 (US$ Million)
6.3 Europe Drug Delivery Market Forecast Analysis

7. Europe Drug Delivery Market Analysis – by Route of Administration

7.1 Injectable Drug Delivery
  • 7.1.1 Overview
  • 7.1.2 Injectable Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Oral Drug Delivery
  • 7.2.1 Overview
  • 7.2.2 Oral Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Transmucosal Drug Delivery
  • 7.3.1 Overview
  • 7.3.2 Transmucosal Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Topical Drug Delivery
  • 7.4.1 Overview
  • 7.4.2 Topical Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 Implantable Drug Delivery
  • 7.5.1 Overview
  • 7.5.2 Implantable Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.6 Ocular Drug Delivery
  • 7.6.1 Overview
  • 7.6.2 Ocular Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)

8. Europe Drug Delivery Market Analysis – by Distribution Channel

8.1 Hospital Pharmacies
  • 8.1.1 Overview
  • 8.1.2 Hospital Pharmacies: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Retail Pharmacies
  • 8.2.1 Overview
  • 8.2.2 Retail Pharmacies: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Online Pharmacies
  • 8.3.1 Overview
  • 8.3.2 Online Pharmacies: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)

9. Europe Drug Delivery Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Clinics: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Home Care Settings
  • 9.2.1 Overview
  • 9.2.2 Home Care Settings: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Other End User
  • 9.3.1 Overview
  • 9.3.2 Other End User : Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)

10. Europe Drug Delivery Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Drug Delivery Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.2.1.1 Europe Drug Delivery Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 UK: Europe Drug Delivery Market Breakdown, by Route of Administration
    • 10.2.1.1.2 UK: Europe Drug Delivery Market Breakdown, by Distribution Channel
    • 10.2.1.1.3 UK: Europe Drug Delivery Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Drug Delivery Market Breakdown, by Route of Administration
    • 10.2.1.2.2 Germany: Europe Drug Delivery Market Breakdown, by Distribution Channel
    • 10.2.1.2.3 Germany: Europe Drug Delivery Market Breakdown, by End User
  • 10.2.1.3 France: Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 France: Europe Drug Delivery Market Breakdown, by Route of Administration
    • 10.2.1.3.2 France: Europe Drug Delivery Market Breakdown, by Distribution Channel
    • 10.2.1.3.3 France: Europe Drug Delivery Market Breakdown, by End User
  • 10.2.1.4 Russia: Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Drug Delivery Market Breakdown, by Route of Administration
    • 10.2.1.4.2 Russia: Europe Drug Delivery Market Breakdown, by Distribution Channel
    • 10.2.1.4.3 Russia: Europe Drug Delivery Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Drug Delivery Market Breakdown, by Route of Administration
    • 10.2.1.5.2 Italy: Europe Drug Delivery Market Breakdown, by Distribution Channel
    • 10.2.1.5.3 Italy: Europe Drug Delivery Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Drug Delivery Market Breakdown, by Route of Administration
    • 10.2.1.6.2 Rest of Europe: Europe Drug Delivery Market Breakdown, by Distribution Channel
    • 10.2.1.6.3 Rest of Europe: Europe Drug Delivery Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Bausch Health Companies Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Baxter International Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Becton Dickinson and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Boehringer Ingelheim International GmbH
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Boston Scientific Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Gerresheimer AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 GlaxoSmithKline Plc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Johnson & Johnson
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Novartis AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Novo Nordisk AS
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Pfizer Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Sever Pharma Solutions
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Drug Delivery Market

  • Bausch Health Companies Inc
  • Baxter International Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc
  • Sever Pharma Solutions
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)